Page 35 - Douala News Today

Around 40 years in the making, the World Health Organization (WHO)-approved RTS,S vaccine developed by British drugmaker GSK is meant to work alongside existing tools such as bed nets to combat malaria, which in Africa kills nearly half a million children under the age of five each year.

He situation suggests that authorities may need to reconsider their outreach strategies and communication channels to bridge the information gap. It is crucial to address the concerns and misconceptions surrounding the vaccination campaign to ensure wider participation and acceptance

The second playing day of the competition took place in Yaounde last weekend.

In recent days, power outages have become increasingly common in several cities in Cameroon, notably in Yaoundé and Douala. The country’s power

As of January 1, 2024, the acquisition of a real estate promoters approval, real estate agents professional card, and condominium syndic card in

So far, the group stages have delivered a host of surprises at this edition of the Africa Cup of Nations. But, fans of the tournament have long come to expect the unexpected.

Cameroon Concord delivers timely and accurate news on Cameroon, covering politics, culture, and more. Trust our engaging content:

Another 19 African countries have plans to join the programme – bringing ‘more than just hope’ to a continent that suffers the vast majority of malaria deaths

The global fight against malaria took a stride forward on Monday as Cameroon started the world's first routine vaccine programme against the mosquito-borne disease, although Reuters journalists witnessed few people in clinics receiving the shot. Around 40 years in the making, the World Health Organization (WHO)-approved RTS,S vaccine developed by British drugmaker GSK is meant to work alongside existing tools such as bed nets to combat malaria, which in Africa kills nearly half a million c...

Cameroon is the first country to implement a routine malaria vaccine program, with 19 other countries set to follow. The development of a second vaccine has eased supply concerns.